Cerebrotendinous xanthomatosis: case report with evidence of oxidative stress (Q48109207)

8 February 2018

title

Cerebrotendinous xanthomatosis: case report with evidence of oxidative stress (English)

1 reference

8 February 2018

cerebrotendinous xanthomatosis

main subject

1 reference

4

1 reference

8 February 2018

Mark Anthony Smith

5

object named as

Mark A Smith

1 reference

8 February 2018

3

Peggy L R Harris

1 reference

8 February 2018

author name string

Luis F Gonzalez-Cuyar

1

1 reference

8 February 2018

Brian Hunter

2

1 reference

8 February 2018

Rudy J Castellani

6

1 reference

8 February 2018

publication date

1 January 2007

1 reference

8 February 2018

published in

Redox Report

1 reference

8 February 2018

volume

12

1 reference

8 February 2018

issue

3

1 reference

8 February 2018

page(s)

119-124

1 reference

8 February 2018

Unusual cerebrotendinous xanthomatosis with fronto-temporal dementia phenotype.

cites work

1 reference

https://api.crossref.org/works/10.1179%2F135100007X200173

Cerebrotendinous xanthomatosis: possible higher prevalence than previously recognized

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F135100007X200173

Frontal lobe dementia with abnormal cholesterol metabolism and heterozygous mutation in sterol 27-hydroxylase gene (CYP27).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F135100007X200173

Diphenylpyraline-responsive parkinsonism in cerebrotendinous xanthomatosis: long-term follow up of three patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F135100007X200173

Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F135100007X200173

Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F135100007X200173

Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F135100007X200173

Cerebrotendinous xanthomatosis: 11-year treatment with chenodeoxycholic acid in five patients. An electrophysiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F135100007X200173

Cerebrotendinous xanthomatosis: treatments with simvastatin, lovastatin, and chenodeoxycholic acid in 3 siblings

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F135100007X200173

Could steroids mask the diagnosis of cerebrotendinous xanthomatosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F135100007X200173

Cholestanol metabolism, molecular pathology, and nutritional implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F135100007X200173

Involvement of oxidative stress in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F135100007X200173

Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F135100007X200173

Structure of advanced Maillard reaction products and their pathological role

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F135100007X200173

Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F135100007X200173

Advanced glycation modification of Rosenthal fibers in patients with Alexander disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F135100007X200173

Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F135100007X200173

Amyloid-beta and tau serve antioxidant functions in the aging and Alzheimer brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F135100007X200173

Tau phosphorylation in Alzheimer's disease: pathogen or protector?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F135100007X200173

Neuropathology of Alzheimer disease: pathognomonic but not pathogenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F135100007X200173

Cerebrotendinous Xanthomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F135100007X200173

Sudden death in epilepsy: a study of incidence in a young cohort with epilepsy and learning difficulty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F135100007X200173

Cerebrotendinous xanthomatosis as a multisystem disease mimicking premature ageing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F135100007X200173

21 January 2018

Identifiers

DOI

10.1179/135100007X200173

1 reference

8 February 2018

release_pvllyauovrghvfzrcnlw6yadre

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pvllyauovrghvfzrcnlw6yadre

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

8 February 2018